Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

A Combined Cell-Worm Approach to Search for Compounds Counteracting the Toxicity of Tau Oligomers in Vivo

Version 1 : Received: 26 July 2022 / Approved: 27 July 2022 / Online: 27 July 2022 (05:10:20 CEST)

How to cite: Natale, C.; Barzago, M.M.; Colnaghi, L.; De Luigi, A.; Orsini, F.; Fioriti, L.; Diomede, L. A Combined Cell-Worm Approach to Search for Compounds Counteracting the Toxicity of Tau Oligomers in Vivo. Preprints 2022, 2022070411 (doi: 10.20944/preprints202207.0411.v1). Natale, C.; Barzago, M.M.; Colnaghi, L.; De Luigi, A.; Orsini, F.; Fioriti, L.; Diomede, L. A Combined Cell-Worm Approach to Search for Compounds Counteracting the Toxicity of Tau Oligomers in Vivo. Preprints 2022, 2022070411 (doi: 10.20944/preprints202207.0411.v1).

Abstract

A clear relationship between the tau assemblies and toxicity has still to be established. To correlate the tau conformation with its proteotoxic effect in vivo we developed an innovative cell-worm-based approach. HEK293 cells expressing tau P301L under a tetracycline-inducible system (HEK T-Rex) were employed to produce different tau assemblies whose proteotoxic potential was evaluated using C. elegans. Lysates from cells induced for five days, significantly reduced the worm’s locomotor activity. This toxic effect was not related to the total amount of tau produced by cells or to its phosphorylation state but was related to the formation of multimeric tau assemblies, particularly tetrameric ones. We investigated the applicability of this approach for testing compounds acting against oligomeric tau toxicity, using doxycycline (Doxy) as prototype drug. Doxy affected the tau solubility and promoted the disassembly of already formed toxic aggregates in lysates of cells induced for five days. These effects translated into a dose-dependent protective action in C. elegans. These findings confirm the validity of the combined HEK T-Rex cells and C. elegans-based approach as a platform for pharmacological screening.

Keywords

tauopathy; tau protein; oligomers; proteotoxicity; C. elegans; tetracyclines.

Subject

MEDICINE & PHARMACOLOGY, Pharmacology & Toxicology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.

We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.